Ryboquin's Spinoff / Spinout Round

Ryboquin raised a round of funding on January 01, 2013. Investors include Ectopharma.

Ryboquin, a drug development company, is focused on commercializing patented technologies in the area of human cancer medicine. The Company's aim is to grow shareholder value by developing new, effect…

Articles about Ryboquin's Spinoff / Spinout Round: